The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability.
Standard
The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability. / Cour, La; Jonas, M; Høj, Berit R; Simon, Ronald; Sauter, Guido; Sauter, Guido; Berchtold, Martin W.
in: MOL ONCOL, Jahrgang 1, Nr. 4, 4, 2008, S. 431-439.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability.
AU - Cour, La
AU - Jonas, M
AU - Høj, Berit R
AU - Simon, Ronald
AU - Sauter, Guido
AU - Sauter, Guido
AU - Berchtold, Martin W
PY - 2008
Y1 - 2008
N2 - The apoptosis linked gene-2 (ALG-2), discovered as a proapoptotic calcium binding protein, has recently been found upregulated in lung cancer tissue indicating that this protein may play a role in the pathology of cancer cells and/or may be a tumor marker. Using immunohistochemistry on tissue microarrays we analysed the expression of ALG-2 in 7371 tumor tissue samples of various origin as well as in 749 normal tissue samples. Most notably, ALG-2 was upregulated in mesenchymal tumors. No correlation was found between ALG-2 staining intensity and survival of patients with lung, breast or colon cancer. siRNA mediated ALG-2 downregulation led to a significant reduction in viability of HeLa cells indicating that ALG-2 may contribute to tumor development and expansion.
AB - The apoptosis linked gene-2 (ALG-2), discovered as a proapoptotic calcium binding protein, has recently been found upregulated in lung cancer tissue indicating that this protein may play a role in the pathology of cancer cells and/or may be a tumor marker. Using immunohistochemistry on tissue microarrays we analysed the expression of ALG-2 in 7371 tumor tissue samples of various origin as well as in 749 normal tissue samples. Most notably, ALG-2 was upregulated in mesenchymal tumors. No correlation was found between ALG-2 staining intensity and survival of patients with lung, breast or colon cancer. siRNA mediated ALG-2 downregulation led to a significant reduction in viability of HeLa cells indicating that ALG-2 may contribute to tumor development and expansion.
U2 - 10.1016/j.molonc.2007.08.002
DO - 10.1016/j.molonc.2007.08.002
M3 - SCORING: Zeitschriftenaufsatz
VL - 1
SP - 431
EP - 439
JO - MOL ONCOL
JF - MOL ONCOL
SN - 1574-7891
IS - 4
M1 - 4
ER -